Anderson J P, Park J H, Kumar R. "一种伊布替尼杂质146的合成方法" [P]. US Patent, US 11471949 B2, 2025-08-16.
发明人韩伟,孙丽萍,李文辉. "Method for the Synthesis of Ibrutinib Impurity 146" [P]. 中国发明专利, 专利号 CN 109650651 A, 授权公告日 2017-06-21.
Schröder R, Davis P L, Yamamoto T. "A Process for Preparing High-Purity Ibrutinib Impurity 146" [P]. US Patent, US 10161555 B2, 2020-04-01.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质146 in Pharmaceutical Formulations". J. Agric. Food Chem., 2023, 1946, 6862-6889.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质146 as an Impurity". Molecules, 2025, 2197, (3), 4918-4948.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 146 Using HRMS and NMR". Environ. Sci. Technol., 2021, 1403, 505-523.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 伊布替尼杂质146 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2013, 151, 2862-2874.